Clearance of polymeric IgA aggregates in humans.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Kidney Diseases

• Publication date

  1989-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0272-6386(89)80167-2PMID 2816927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding of IgA to erythrocytes from patients with IgA nephropathy.

  1988cited by this paper
• Lack of complement activation by human IgA immune complexes.

  1988cited by this paper
• Failure to relate mononuclear phagocyte system function to HLA-A, B, C, DR, DQ antigens in membranous nephropathy.

  1987cited by this paper
• Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

  1987cited by this paper
• Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate.

  1987cited by this paper
• The role of mesangial complement in the hematuria of experimental IgA nephropathy.

  1987cited by this paper
• Complement activation in IgA nephropathy.

  1987cited by this paper
• Complement activation in experimental IgA nephropathy: an antigen-mediated process.

  1987cited by this paper
• Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis.

  1987cited by this paper
• Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.

  1986cited by this paper
• Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli.

  1986cited by this paper
• Circulating Fc-receptor blocking factors in IgA nephropathies.

  1985cited by this paper
• Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.

  1985cited by this paper
• Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.

  1984cited by this paper
• Localization and serum concentration of secretory component during massive necrosis of human liver.

  1984cited by this paper
• Experimental IgA nephropathy. Factors governing the persistence of IgA-antigen complexes in the circulation of mice.

  1984cited by this paper
• The role of IgA and IgG immune complexes in IgA nephropathy.

  1984cited by this paper
• Monocyte-macrophage system function in primary IgA nephropathy.

  1984cited by this paper
• IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis.

  1984cited by this paper
• Modulation of mononuclear phagocyte function by intravenous gamma-globulin.

  1984cited by this paper
• Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.

  1983cited by this paper
• Impaired fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults

  1983cited by this paper
• Primate erythrocyte-immune complex-clearing mechanism.

  1983cited by this paper
• Mesangial IgA nephropathy: detection of defective reticulophagocytic function in vivo.

  1983cited by this paper
• Interaction between the macrophage system and IgA immune complexes in IgA nephropathy.

  1983cited by this paper
• Mesangial deposition of J chain-linked polymeric IgA in IgA nephropathy.

  1983cited by this paper
• Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.

  1982cited by this paper
• Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A.

  1982cited by this paper
• Immunopathology, extent and course of glomerulonephritis with crescent formation.

  1982cited by this paper
• Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content.

  1982cited by this paper
• Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity.

  1982cited by this paper
• Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.

  1981cited by this paper
• Red cell immune adherence (RCIA): its application in cancer and autoimmune disease.

  1981cited by this paper
• IGA in human bile and liver.

  1981cited by this paper
• The specificity of receptors for IgA on human peripheral polymorphonuclear cells and monocytes.

  1981cited by this paper
• High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

  1981cited by this paper
• [New possibilities for immunoglobulin substitution in antibody deficiency syndrome].

  1980cited by this paper
• Physicochemical and functional relationships of immune complexes.

  1980cited by this paper
• [Therapeutic use of immunoglobulins in children (author's transl)].

  1980cited by this paper
• Experimental IgA nephropathy

  1979cited by this paper
• Chromatographic separation and purification of secretory IgA from human milk.

  1977cited by this paper
• SEROTYPING FOR HOMOTRANSPLANTATION: XXXI. A 45‐Minute Microcytotoxicity Test1

  1969cited by this paper
• SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TEST

  1968cited by this paper
• A method of trace iodination of proteins for immunologic studies.

  1966cited by this paper

• Evidence-based clinical practice guidelines for IgA nephropathy 2014

  2016cites this paper
• IgA Nephropathy and Related Diseases

  2015cites this paper
• IgA Nephropathy and Schöenlein-Henoch Purpura Nephritis

  2014cites this paper
• Secondary IgA nephropathy.

  2008cites this paper
• Chapter The role of SIgA and complement in IgA-nephropathy

  2008cites this paper
• The role of secretory IgA and complement in IgA nephropathy.

  2008cites this paper
• Immune regulation in IgA nephropathy

  2008cites this paper
• Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.

  2007cites this paper
• The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes.

  2007cites this paper
• Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates.

  2006cites this paper
• Chapter 92 – IgA Nephropathy and Related Diseases

  2005cites this paper
• Immunopathogenesis of experimental IgA nephropathy

  2004cites this paper
• Age-dependent decrease of polymeric Ig receptor expression and IgA elevation in ddY mice: a possible cause of IgA nephropathy

  2004cites this paper
• Liver and kidney diseases.

  2002cites this paper
• Mechanisms of mesangial injury in glomerular diseases.

  2000cites this paper
• Processing of IgA aggregates in a rat model of chronic liver disease.

  1997cites this paper
• Future Directions in the Treatment of IgA Nephropathy

  1997cites this paper
• IgA nephropathy--human disease and animal model.

  1997cites this paper
• Transforming growth factor-beta 1 (TGF-beta 1) down-regulates IgA Fc-receptor (CD89) expression on human monocytes.

  1996cites this paper
• Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells

  1996cites this paper
• Alcohol misuse and renal damage

  1996cites this paper
• Treatment of IgA nephropathy: an overview

  1996cites this paper
• Henoch-Schönlein disease with IgA nephropathy associated with chronic alcoholic liver disease.

  1995cites this paper
• Low-antigen-content diet in the treatment of patients with IgA nephropathy

  1994cites this paper
• Different elimination of circulating IgA immune complexes in rat and guinea pig. Blood clearance, organ distribution and cellular uptake in the liver.

  1994cites this paper
• Etiology of IgA nephropathy syndrome

  1994cites this paper
• Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake.

  1994cites this paper
• Experimental immunoglobulin A nephropathy induced by gram-negative bacteria.

  1993cites this paper
• Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.

  1993cites this paper
• Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy.

  1992cites this paper
• Both Kupffer cells and liver endothelial cells play an important role in the clearance of IgA and IgG immune complexes.

  1992cites this paper
• The fate of aggregated immunoglobulin A injected in IgA nephropathy patients and healthy controls.

  1991cites this paper
• Kupffer cell depletion in vivo results in clearance of large‐sized IgA aggregates in rats by liver endothelial cells

  1991cites this paper
• Complement enhances the clearance of large‐sized soluble IgA aggregates in rats

  1991cites this paper
• Immunoregulatory factors in the pathogenesis of IgA nephropathy.

  1990cites this paper
• Effects of a gluten-free diet in primary IgA nephropathy.

  1990cites this paper